Literature DB >> 21193224

Cell adhesion and communication proteins are differentially expressed in melanoma progression model.

Gisele Gargantini Rezze1, José Humberto Tavares Guerreiro Fregnani, João Duprat, Gilles Landman.   

Abstract

Cutaneous melanoma is an aggressive cancer derived from skin melanocytes. Tissue microarrays are being used to evaluate the roles of numerous proteins implicated in some of the pathways involved in melanoma pathogenesis. Based on a previous study using a complementary DNA microarray platform, the aim of this study was to evaluate the immunohistochemical expression of the adhesion and communication molecules connexin 43, desmocollin 3, cytokeratin 5, kallikrein 6, and kallikrein 7 in a melanoma progression model. We analyzed 59 common nevi, 22 atypical nevi, and 162 invasive and 29 metastatic melanomas on tissue microarrays using digital microscopy. The expression of desmocollin 3 and connexin 43 was higher in melanomas (P < .001). Kallikrein 6 expression was higher in melanomas than in common nevi (P < .006). The expression of cytokeratin 5 and kallikrein 7 was higher in atypical nevi than in melanomas (P < .001) and was higher in melanomas than in common nevi (P < .001). The expression of desmocollin 3 and connexin 43 in melanomas indicates loss of cell-cell interactions, which starts in the early steps of the melanoma progression model. Keratin expression in melanomas may play a particular role during melanocyte development. The expression of kallikrein 7 and kallikrein 6 in melanomas may be responsible for the loss of cell-cell adhesion.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193224     DOI: 10.1016/j.humpath.2010.09.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

1.  Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.

Authors:  Yijing Yu; Ioannis Prassas; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

2.  No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.

Authors:  Dominik Riss; Johannes Pammer; Matthaeus C Grasl; Alexandra Kaider; Sven Schneider; Boban M Erovic
Journal:  Wien Klin Wochenschr       Date:  2014-10-10       Impact factor: 1.704

Review 3.  An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs.

Authors:  Jing Wang; Yifan Zhang; Ning Zhang; Chuandong Wang; Tanja Herrler; Qingfeng Li
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

4.  Connexin 43: Key roles in the skin.

Authors:  Xiao-Fei Zhang; Xiaofeng Cui
Journal:  Biomed Rep       Date:  2017-05-03

5.  Connexin 43 (Cx43) Expression in Laryngeal Squamous Cell Carcinomas: Preliminary Data on Its Possible Prognostic Role.

Authors:  Lidia Puzzo; Rosario Caltabiano; Rosalba Parenti; Serena Trapasso; Eugenia Allegra
Journal:  Head Neck Pathol       Date:  2016-01-09

6.  The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases.

Authors:  Silke Schüle; Claudia Neuhäuser; Falk Rauchfuß; Thomas Knösel; Utz Settmacher; Annelore Altendorf-Hofmann
Journal:  Int J Colorectal Dis       Date:  2013-08-24       Impact factor: 2.571

Review 7.  Connexins and their channels in inflammation.

Authors:  Joost Willebrords; Sara Crespo Yanguas; Michaël Maes; Elke Decrock; Nan Wang; Luc Leybaert; Brenda R Kwak; Colin R Green; Bruno Cogliati; Mathieu Vinken
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-07-07       Impact factor: 8.250

8.  Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.

Authors:  Stefanie Krenzer; Heike Peterziel; Cornelia Mauch; Sachiko I Blaber; Michael Blaber; Peter Angel; Jochen Hess
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

Review 9.  Inhibitors of connexin and pannexin channels as potential therapeutics.

Authors:  Joost Willebrords; Michaël Maes; Sara Crespo Yanguas; Mathieu Vinken
Journal:  Pharmacol Ther       Date:  2017-07-15       Impact factor: 12.310

10.  Identification of ovarian cancer associated genes using an integrated approach in a Boolean framework.

Authors:  Gaurav Kumar; Edmond J Breen; Shoba Ranganathan
Journal:  BMC Syst Biol       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.